Evidence map›Paper›PMID 38026484›Full record

ReviewFrontiers in surgery2023

Application possibilities of artificial intelligence in facial vascularized composite allotransplantation-a narrative review.

Leonard Knoedler, Samuel Knoedler, Omar Allam, Katya Remy, Maximilian Miragall, Ali-Farid Safi, Michael Alfertshofer, Bohdan Pomahac, Martin Kauke-Navarro

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Leonard KnoedlerDepartment of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Samuel KnoedlerDivision of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, United States.
Omar AllamDivision of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, United States.
Katya RemyDepartment of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Maximilian MiragallDepartment of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Ali-Farid SafiCraniologicum, Center for Cranio-Maxillo-Facial Surgery, Bern, Switzerland.
Michael AlfertshoferDivision of Hand, Plastic and Aesthetic Surgery, Ludwig-Maximilians University Munich, Munich, Germany.
Bohdan PomahacDivision of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, United States.
Martin Kauke-NavarroDivision of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, United States.
Yale New Haven Hospital · USUniversity Hospital Regensburg · DELudwig-Maximilians-Universität München · DEUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facial vascularized composite allotransplantation (FVCA) is an emerging field of reconstructive surgery that represents a dogmatic shift in the surgical treatment of patients with severe facial disfigurements. While conventional reconstructive strategies were previously considered the goldstandard for patients with devastating facial trauma, FVCA has demonstrated promising short- and long-term outcomes. Yet, there remain several obstacles that complicate the integration of FVCA procedures into the standard workflow for facial trauma patients. Artificial intelligence (AI) has been shown to provide targeted and resource-effective solutions for persisting clinical challenges in various specialties. However, there is a paucity of studies elucidating the combination of FVCA and AI to overcome such hurdles. Here, we delineate the application possibilities of AI in the field of FVCA and discuss the use of AI technology for FVCA outcome simulation, diagnosis and prediction of rejection episodes, and malignancy screening. This line of research may serve as a fundament for future studies linking these two revolutionary biotechnologies.

Indexed as

AIartificial intelligencedeep learningface transplantfacial VCAmachine learningvascularized composite allotransplantationVCA

Identifiers

PMID38026484
PMCPMC10646214
OpenAlexW4388032248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.